SAN DIEGO, Oct. 12, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced today that management willpresent at the 2017 BIO Investor Forum on Tuesday, October 17th, at 9:15 AM PDT (12:15 PM EDT).
Investors, analysts, and the general public are
Orexigen Investor Contact:Jason Keyes, Chief Financial Officer+1-858- [email protected]
Orexigen Media Contact:Erika HackmannY&[email protected]
View original content:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-at-the-2017-bio-investor-forum-300536244.html
SOURCE Orexigen Therapeutics, Inc.
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All